Sequential evaluation of hepatic functional reserve by99mTechnetium-galactosyl human serum albumin scinitigraphy after proton beam therapy: a report of three cases and a review of the literatures
Open Access
- 1 January 2006
- journal article
- case report
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 45 (8), 1102-1107
- https://doi.org/10.1080/02841860600690347
Abstract
The treatment strategy for malignant liver tumors should be appropriately determined because post-treatment quality of life greatly depends on the patients’ residual hepatic function. In this report, we present three patients with malignant liver tumors treated by proton beam therapy in whom pre- and post-therapeutic hepatic functional reserves were evaluated sequentially for more than a year by 99mTechnetium-galactosyl human serum albumin (99mTc-GSA) scintigraphy. All three patients exhibited the distinctive time course of 99mTc-GSA uptake efficiency, which suggested a transient decline in the ratio of liver activity to heart and liver activity at 15 minutes (LHL15) 3–6 months after proton beam therapy. This change was not in parallel with that expected from a functioning normal liver tissue volume. In a year after proton beam therapy, LHL15 recovered nearly to the pre-treatment level in all three patients. Our observations may be related to the up-regulation of receptor-mediated 99mTc-GSA uptake during hepatic regeneration after proton beam therapy.Keywords
This publication has 21 references indexed in Scilit:
- Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombusCancer, 2005
- Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 PatientsClinical Cancer Research, 2005
- Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular CarcinomaJournal of Clinical Oncology, 2005
- Changes in Serum Levels of Growth Factors in Healthy Individuals After Living Related Liver DonationTransplantation Proceedings, 2005
- Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixedActa Oncologica, 2005
- Number of patients potentially eligible for proton therapyActa Oncologica, 2005
- INDUCTION OF HEPATOCYTE GROWTH FACTOR IN THE LIVER, KIDNEY AND LUNG FOLLOWING TOTAL BODY IRRADIATION IN RATCytokine, 1996
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995
- Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver functionJournal of Hepatology, 1993
- A Study of Normal Liver and Livers with Chronic Hepatitis and CirrhosisAnnals of Surgery, 1987